Multiple sclerosis is a condition in which the immune system attacks myelin, the sheath that wraps around nerve cells. MS is more common in women than men, and can strike at any age, although it is more commonly diagnosed between the ages of 20 and 50. The symptoms of MS can vary widely, depending on the nerves that are affected. Some common MS symptoms are extreme fatigue, numbness and tingling, vision problems, and weakness or balance problems.
Multiple Sclerosis News
FRIDAY, Feb. 20, 2015 (HealthDay News) — Women with multiple sclerosis (MS) have lower levels of important antioxidant and anti-inflammatory nutrients than those without the disease, new research finds. “Since MS is a chronic inflammatory disorder, having enough nutrients with anti-inflammatory properties may help prevent the disease or reduce the risk of attacks for those who [...]
By Amy NortonHealthDay Reporter TUESDAY, Jan. 20, 2015 (HealthDay News) — A therapy that uses patients’ own primitive blood cells may be able to reverse some of the effects of multiple sclerosis, a preliminary study suggests. The findings, published Tuesday in the Journal of the American Medical Association, had experts cautiously optimistic. But they also stressed that the [...]
By Amy NortonHealthDay Reporter TUESDAY, Jan. 20, 2015 (HealthDay News) — Women who harbor the stomach bacteria Helicobacter pylori (or H. pylori) may be less likely to develop multiple sclerosis (MS), a new study suggests. In the study, researchers found that among women with MS — an often disabling disease of the central nervous system — 14 [...]
TUESDAY, Jan. 6, 2015 (HealthDay News) — The HPV vaccine for cervical cancer and other diseases doesn’t increase the risk for multiple sclerosis or other central nervous system disorders, according to a new study. More than 175 million doses of HPV vaccines have been distributed worldwide to girls and young women — and more recently males [...]
By Dennis ThompsonHealthDay Reporter MONDAY, Dec. 29, 2014 (HealthDay News) — An experimental therapy that kills off and then “resets” the immune system has given three years of remission to a small group of multiple sclerosis patients, researchers say. About eight in 10 patients given this treatment had no new adverse events after three years. And nine [...]